News | January 22, 2008

Surgeons Demo Robotic Coronary Revascularization, Mitral Valve Repair

January 22, 3008 - Cardica Inc. and Intuitive Surgical Inc. will host an evening symposium, demonstrating how surgeons can automate the attachment of blood vessel grafts during coronary artery bypass graft (CABG) procedures, replacing traditional hand-sewn sutures.

The symposium, �Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair,� will feature Intuitive�s da Vinci Surgical System and Cardica�s C-Port Distal Anastomosis Systems. The educational event will take place on Sunday, January 27, from 7 to 9 p.m. (EST), at the Renaissance Hotel Grand Ballroom in Fort Lauderdale, FL, during the 44th Annual Meeting of The Society of Thoracic Surgeons (STS).

�This symposium offers cardiothoracic surgeons an opportunity to learn from their peers who are leading the adoption of beating heart robotic CABG surgery and the establishment of robotic mitral valve surgery as standard of care,� said Louis A. Brunsting, III, M.D., cardiothoracic surgeon for Centennial Medical Center in Nashville, Tennessee. �The Cardica C-Port systems and da Vinci Surgical System�may facilitate a more widespread adoption of completely closed-chest, robotic-assisted coronary artery bypass grafting.�

During the symposium, five cardiac surgeons will present topics, including: Husam Balkhy, M.D., of The Wisconsin Heart Hospital; Daniel Bethencourt, M.D., of Long Beach Memorial Medical Center; Louis A. Brunsting, III, M.D., of Centennial Medical Center; Douglas A. Murphy, M.D., of Saint Joseph's Hospital; J. Michael Smith, M.D., of Good Samaritan Hospital.

For more information:

Related Content

Videos | Heart Valve Technology | May 20, 2019
A demonstration of how to calculate the neo-left ventricular outflow tract (neo-LVOT) on CT imaging for a transcathet
Study Finds TAVR Can Be Considered for Patients in All Surgical Risk Classes
News | Heart Valve Technology | May 08, 2019
Transcatheter aortic valve replacement (TAVR) has been studied as an alternative to surgical aortic valve replacement...
Boston Scientific Receives FDA Approval for Lotus Edge Aortic Valve System
Feature | Heart Valve Technology | April 23, 2019 | Dave Fornell, Editor
Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) approval for the Lotus Edge...
New Consensus Document Explores Optimized Care for Valvular Heart Disease Patients
News | Heart Valve Technology | April 22, 2019
April 22, 2019 — Five cardiovascular professional societies released a new consensus document on optimizing care for
Mick Jagger Recovering After TAVR Procedure
News | Heart Valve Technology | April 08, 2019 | Jeff Zagoudis, Associate Editor
Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic valve valve...
 Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting
News | Heart Valve Technology | April 03, 2019
April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut transc
TAVR Outperforms Surgery in Younger, Low-Risk Aortic Stenosis Patients
News | Heart Valve Technology | March 22, 2019
Among patients with severe symptomatic aortic stenosis at low surgical risk, transcatheter aortic valve replacement (...
ACC Launches Transcatheter Valve Certification
News | Heart Valve Technology | March 14, 2019
March 14, 2019 — Beginning in mid-2019, hospitals performing...
Overlay Init